Evidence map›Paper›PMID 39903478›Full record

Trial reportDiabetes care2025

Health-Related Quality of Life and Health Utility After Metabolic/Bariatric Surgery Versus Medical/Lifestyle Intervention in Individuals With Type 2 Diabetes and Obesity: The ARMMS-T2D Study.

Donald C Simonson, William F Gourash, David E Arterburn, Bo Hu, Sangeeta R Kashyap, David E Cummings, Mary-Elizabeth Patti, Anita P Courcoulas, Ashley H Vernon, John M Jakicic and 4 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01047735 (Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes), which is not on this map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01047735 naactive not recruitingnot on this map

Randomized Trial to Compare Surgical and Medical Treatments for Type 2 Diabetes (Triabetes) - Alliance of Randomized Trials of Medicine vs. Metabolic Surgery in Type 2 Diabetes ARMMST2D)

TypeinterventionalSponsorUniversity of PittsburghRan2009 to 2028Enrolled69ConditionsType 2 Diabetes Mellitus, ObesityArmsRoux-en-Y Gastric Bypass Surgery, Laparoscopic Adjustable Gastric Banding, Lifestyle Weight Loss Intervention
3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Observational
  4. Effects of obesity on brain health and cognition.Nature reviews. Neurology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Impact of body weight on quality of life trajectories following metabolic bariatric surgery in individuals with obesity: a longitudinal study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2026
    Observational
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Donald C SimonsonBrigham and Women's Hospital, Boston, MA.ORCID 0000-0002-4670-6290
William F GourashUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
David E ArterburnKaiser Permanente Washington Health Research Institute, Seattle, WA.
Bo HuCleveland Clinic, Cleveland, OH.
Sangeeta R KashyapCleveland Clinic, Cleveland, OH.
David E CummingsUniversity of Washington Medical School, Seattle, WA.
Mary-Elizabeth PattiHarvard Medical School, Boston, MA.
Anita P CourcoulasUniversity of Pittsburgh Medical Center, Pittsburgh, PA.ORCID 0000-0002-4973-7869
Ashley H VernonBrigham and Women's Hospital, Boston, MA.
John M JakicicUniversity of Pittsburgh Medical Center, Pittsburgh, PA.
Sarah KirschlingCleveland Clinic, Cleveland, OH.
Ali AminianCleveland Clinic, Cleveland, OH.ORCID 0000-0001-5756-9917
Philip R SchauerCleveland Clinic, Cleveland, OH.
John P KirwanCleveland Clinic, Cleveland, OH.ORCID 0000-0001-7321-9917

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes - (ARMMS-T2D)U01DK114156 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI AMINIAN, ALI, KIRWAN, JOHN P. · 2017 to 2022
$8.9M
Effect of Bariatric Surgery on Mechanisms of Type 2 Diabetes: The B2D TrialR01DK089547 · NIDDK · CLEVELAND CLINIC LERNER COM-CWRU · PI KASHYAP, SANGEETA R, KIRWAN, JOHN P. · 2010 to 2013
$1.9M
Feasibility, Efficacy, and Mechanisms of Surgical vs Medical Diabetes TreatmentR01DK089528 · NIDDK · UNIVERSITY OF WASHINGTON · PI CUMMINGS, DAVID EUSTACE, FLUM, DAVID R · 2010 to 2012
$1.7M
A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 DiabetesRC1DK086037 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COURCOULAS, ANITA P · 2009 to 2010
$1.0M
Comparative Effectiveness of Medical Therapy vs. Bariatric Surgery for Obese T2DMRC1DK086918 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI GOLDFINE, ALLISON B, LAUTZ, DAVID BRADLEY · 2009 to 2010
$1.0M
A Randomized Trial to Compare Surgical and Medical Treatments for Type 2 DiabetesR01DK095128 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI COURCOULAS, ANITA P · 2012 to 2014
$879k
Durability and Mechanisms of Bariatric Surgery vs Medical Therapy in Obese T2DR56DK095451 · NIDDK · JOSLIN DIABETES CENTER · PI GOLDFINE, ALLISON B, LAUTZ, DAVID BRADLEY · 2012 to 2013
$277k
NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK089528NIDDK NIH HHS R01 DK089547NIDDK NIH HHS R01 DK095128NIDDK NIH HHS R56 DK095451NIDDK NIH HHS RC1 DK086037NIDDK NIH HHS RC1 DK086918NIDDK NIH HHS U01 DK114156
6 · The paper itself

Abstract

objectiveType 2 diabetes and obesity are associated with reduced health-related quality of life (HRQoL) and health utility (HU), but long-term effects of metabolic/bariatric surgery (MBS) compared with those of medical/lifestyle intervention (MLI) on these outcomes are unclear. RESEARCH DESIGN AND

methodsWe studied 228 individuals with type 2 diabetes and obesity randomly assigned to MBS (Roux-en-Y gastric bypass, sleeve gastrectomy, or gastric band; n = 152) or MLI (n = 76) in the ARMMS-T2D study. HRQoL (36-Item Short-Form Health Survey [SF-36], including Physical Component Score [PCS] and Mental Component Score [MCS]) and HU (Short Form 6 Dimensions [SF-6D]) were measured annually up to 12 years.

resultsAt baseline, participants' mean ± SD age was 49.2 ± 8.0 years, 68.4% were female, BMI was 36.3 ± 3.4 kg/m2, and HbA1c was 8.7 ± 1.6%. PCS improved significantly more in the MBS versus MLI group over 12 years (+2.37 ± 0.53 vs. -0.95 ± 0.73; difference 3.32 ± 0.85; P < 0.001). MBS was associated with better general health (P < 0.001), physical functioning (P = 0.001), and vitality (P = 0.003). Reduction in BMI was greater after MBS versus MLI (P < 0.001) and correlated with improved PCS (r = -0.43; P < 0.001). Change in PCS was not associated with change in HbA1c. MCS changed minimally from baseline and was similar between MBS and MLI groups during follow-up (-0.21 ± 0.61 vs. -0.89 ± 0.84; difference 0.68 ± 0.97; P = 0.48). Improvements in HU were greater in the MBS versus MLI group over 12 years (+0.02 ± 0.01 vs. -0.01 ± 0.01; difference 0.03 ± 0.01; P = 0.003).

conclusionsMetabolic surgery produces sustained weight loss and improves PCS, general health, physical functioning, vitality, and HU in individuals with type 2 diabetes and obesity compared with medical therapy up to 12 years after intervention.

Indexed as

Bariatric SurgeryDiabetes Mellitus, Type 2ObesityQuality of LifeAdultFemaleHumansLife StyleMaleMiddle Aged

Identifiers

PMID39903478
PMCPMC11932816

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.